Ian C. Wildgoose Brown


Wildgoose Brown, Ian

Ian Wildgoose Brown has a general corporate practice with an emphasis on mergers and acquisitions and capital markets transactions for companies at all stages of growth. He regularly advises emerging companies with respect to a wide range of issues, including debt and equity financings and general corporate matters. He is also a member of the firm's FinTech Group.

Prior to joining WilmerHale, Mr. Wildgoose Brown was a summer associate with the Toronto office of Davies Ward Phillips & Vineberg LLP, where he focused on general corporate and securities law matters.

Representative Matters

  • Represented Durata Therapeutics, Inc., a public pharmaceutical company, in its initial public offering and in a follow-on offering of common stock
  • Represented a venture-backed pharmaceutical company in its initial public offering of common stock
  • Represented WEX Inc., a public payment processing company and financial institution, in a private placement of senior secured notes 
  • Represented Savient Pharmaceuticals, Inc., a public biopharmaceutical company, in a financing and debt restructuring by means of exchange and purchase agreements 
  • Represented a leading public financial institution in various capital market transactions 
  • Represented various underwriters in connection with public offerings of common stock by public pharmaceutical and technology companies
  • Represented Akamai Technologies, Inc., a public Internet technology company, in its cross-border acquisition of a private software company
  • Represented Bristol-Myers Squibb Company, a public pharmaceutical company, in various related transactions
  • Represented a leading public FinTech company in its cross-border acquisition of a private software-as-a-service company
  • Represented principal investors in a venture-backed pharmaceutical company in connection with its sale to a public acquiror

Publications & News


November 6, 2013

Social Media and Regulation FD

An overview of the intersection between Social Media and Regulation FD, co-authored by Meredith Cross, Ian Wildgoose Brown and Jennifer Zepralka for distribution at Practising Law Institute's 45th Annual Institute on Securities Regulation.

October 24, 2013

Five Key Legal Requirements and Five Best Practices for Complying With Them

A blog post by Ian Wildgoose Brown published in the WilmerHale FinTech Blog.

August 26, 2013

Direct Edge and BATS Global Markets Agree to Merge

WilmerHale is representing its longstanding client, Direct Edge, in its recently announced merger with BATS Global Markets.

May 6, 2013

2013 Venture Capital Report

Our 2013 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns, an analysis of trends in venture capital financing and VC-backed company M&A deal terms, a look at the federal tax advantages of investments in “qualified small business stock,” and a discussion of JOBS Act benefits for startups that never plan to go public.

April 23, 2013

Data Security Considerations for FinTech Companies

An article by Ian C. Wildgoose Brown, appearing in the Bloomberg Law Banking Report.

August 31, 2012

Hard to Swallow: The Canadian Poison Pill From an American Perspective

An article by Ian C. Wildgoose Brown, appearing in the Seton Hall Legislative Journal.


Skip Navigation Links.


JD, Harvard Law School, 2011, Online Managing Editor, Harvard Business Law Review

BAH, History, with distinction, Queen's University, 2008

Bar Admissions

New York